The management of symptomatic benign prostatic hyperplasia with the once-daily alpha 1 blocker, terazosin.

Woods, A L

Woods, A L.

Affiliation

Woods AL; Department of Urology, Naval Hospital, Orlando, FL 32813-5200.

Mil Med ; 157(7): 361-4, 1992 Jul.

Article in En | MEDLINE | ID: mdl-1382248

Subject(s)

Adrenergic alpha-Antagonists/administration & dosage; Prazosin/analogs & derivatives; Prostatic Hyperplasia/drug therapy; Adrenergic alpha-Antagonists/therapeutic use; Aged; Drug Administration Schedule; Florida; Follow-Up Studies; Hospitals, Military; Humans; Male; Middle Aged; Prazosin/administration & dosage; Prazosin/therapeutic use; Prostatic Hyperplasia/physiopathology; Urodynamics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Prazosin / Adrenergic alpha-Antagonists Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Mil Med Year: 1992 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links